Stohr R, Brandenburg VM, Heine GH, Maeder MT, et al. Limited role for fibroblast growth factor 23 in assessing prognosis in heart failure patients: data from the TIME-CHF trial. Eur J Heart Fail 2020 Feb 5. doi: 10.1002/ejhf.1749.
PMID: 32020782